AXGT
AxonDAO is dedicated to nurturing human relationships and advancing scientific research through biometric data. The personal data market, currently valued at $1.61 trillion, is projected to grow to $17.06 trillion by 2029 with the integration of high-quality biometric data. AxonDAO's governance token, $AXGT, is an Ethereum-based token with bridges to Arbitrum and BASE coming soon. $AXGT is undergoing a security audit by Certik. The token is available on UniSwap and will be submitted for listing on major Tier 1 exchanges for easier access. $AXGT's utility includes voting on projects to be funded, submitting projects, use in data collection within the AxonDAO ecosystem, and more. The current market cap is $44.7M, with a fully diluted valuation (FDV) of $271M, and is currently priced at $0.271 per $AXGT.
1.3M
autimom2@mail.com
Ashleigh Harp
Mack Stachowiak- CTO William Laurent- Chief of Content Tharusha Jayasena-Chief Science officer
Pioneering the Future of Health with Blockchain and AI AxonDAO stands at the cutting edge of health science, redefining the interaction between individuals and their health data through the power of blockchain technology and artificial intelligence. Our foundation is built on the innovative use of precognitive algorithms, drawing from a rich tapestry of biometrics, genomic data, and other critical health indicators, to not only monitor but also predict health outcomes.
Our unique dual-token system embodies our commitment to robust governance, compliance, and active global community participation. With roots deeply embedded in telehealth and clinical research, AxonDAO is poised to address the most pressing healthcare challenges of our time. We are dedicated to ensuring transparency and security in health data through the principles of decentralization, marking a new era in patient-centric care.